Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

InGeneron CEO and leadership

Zippia score 3.8
OverviewSalaryRevenue

Reviews

Competitors

CEO & Executives

InGeneron CEO and executives

Executive Summary. Based on our data team's research, Angelo Moesslang is the InGeneron's CEO. InGeneron has 32 employees, of which 14 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The InGeneron executive team is 57% female and 43% male.
  • 71% of the management team is White.
  • 8% of InGeneron management is Hispanic or Latino.
  • 12% of the management team is Black or African American.
Work at InGeneron?
Share your experience

Rate InGeneron's leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Angelo Moesslang

CEO

Angelo Moesslang's LinkedIn

Angelo Moesslang was named Chief Financial Officer of Fresenius Medical Care North America in August of 2010. He relocated to the Boston area from his native Germany. He began his career with Fresenius Medical Care in Germany in 1995, and held a variety of positions, including: Head of Investor Relations, Vice President of Business Development and Regional Director of NephroCare in Asia Pacific based in Hong Kong, and most recently, Chief Financial Officer of EAMELA (Europe, Africa, Middle East, Latin America). Prior to joining Fresenius, Angelo served as a scientific assistant to the faculty of Business Administration of the University of Stuttgart Hohenheim. He holds a Doctorate in Business Administration from University Stuttgart Hohenheim, and a Graduate Degree in Economics from Ludwigs-Maximilians University in Munich. In his leisure time, Angelo and his wife enjoy traveling, listening to a variety of music, exploring the Boston area, and especially enjoy entertaining friends with good food, wine and conversation.

He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.

Board Member

He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.'s LinkedIn

He Worked At Acelity As Lead Product Development Engineer Developing New Negative Pressure Therapy Devices Within the Prevena and Abthera Surgical Product Lines. Before Acelity David Developed Mechanical and Electromechanical Drug Delivery Systems At Dca Design International In the Uk. David Received His Degree In Mechanical Engineering Specializing In Product Design From the University of Glasgow. David Mercer Has More Than 12 Years of Product Development Experience In Medical Devices. Previously

Board Member

He Worked At Anderson Cancer Center In the Department of Molecular Pathology. Christopher Joined Ingeneron In 2015 As European Director of Medical and Scientific Affairs Before Taking On the Role of Global Director of Medical and Scientific Affairs In 2020. Christopher Received His Medical Degree From Pmu Salzburg In Austria. Christopher Alt Has 15 Years of Research Experience In Medicine and Has A Proven Track Record of Clinical Trial Management. Previously M.D.

Board Member

He Worked At Anderson Cancer Center In the Department of Molecular Pathology. Christopher Joined Ingeneron In 2015 As European Director of Medical and Scientific Affairs Before Taking On the Role of Global Director of Medical and Scientific Affairs In 2020. Christopher Received His Medical Degree From Pmu Salzburg In Austria. Christopher Alt Has 15 Years of Research Experience In Medicine and Has A Proven Track Record of Clinical Trial Management. Previously M.D.'s LinkedIn

Inc. Bobby I. Griffin Retired From A 25-Year Career With Medtronic Where He Held Various Executive-Level Positions, Including President of Medtronic’S Crm Business From 1991 To 1998. He Manages His Own Fund of Companies and Serves On the Advisory Boards of Affinity Capital Management Fund III and IV and Sapient Capital Management Fund, In Which He Also Invests. In Addition, Bobby Has Served On the Board of Directors of Several Public Companies, Including Mts Systems Corporation and Urologix, Inc., and Is Currently A Director of Several Private Companies.

Board Member

Klaus L. Keller

Board Member

Scientific Services Inc. Jerry C. Griffin Is President of Griffin & Schwartz A Management Consulting Firm In the Health Care Products Field. He Has Assisted Several Development Stage Companies In Areas Ranging From Venture and Public Financing To Fda and Clinical Trial Strategy. He Is Currently A Member of the Boards of Directors of A Number of Private Companies. During His Academic Tenure, Jerry Held Leadership Positions In Several National and International Cardiology Organizations and Is the Author Or Coauthor of Five Books, Four Patents, and Over 170 Medical and Scientific Articles.

Board Member

Scientific Services Inc. Jerry C. Griffin Is President of Griffin & Schwartz A Management Consulting Firm In the Health Care Products Field. He Has Assisted Several Development Stage Companies In Areas Ranging From Venture and Public Financing To Fda and Clinical Trial Strategy. He Is Currently A Member of the Boards of Directors of A Number of Private Companies. During His Academic Tenure, Jerry Held Leadership Positions In Several National and International Cardiology Organizations and Is the Author Or Coauthor of Five Books, Four Patents, and Over 170 Medical and Scientific Articles.'s LinkedIn

Fabian Alt

Chief Financial Officer

Fabian Alt's LinkedIn

Fabian Alt, M.Sc., is CFO for InGeneron, Inc.. Previously, he worked at Goldman Sachs in the Investment Banking Division in London. His experience extends across more than 20 completed capital market and M&A transactions, including several equity capital offerings and IPOs with >$500m deal value. Mr. Alt holds a M.Sc. Finance from the London School of Economics and Political Science (LSE), earned an Honors Master in Technology Management from the TU Munich/LMU Munich and received a Diploma/M.Sc. in Physics after studying at TU Munich and Massachusetts Institute of Technology (MIT).

Amber Langner

Board Member

Kent Lehr

Board Member

Do you work at InGeneron?

Does leadership effectively guide InGeneron toward its goals?

InGeneron jobs

InGeneron founders

Name & TitleBio
He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.

Board Member

He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.'s LinkedIn

InGeneron board members

Name & TitleBio
He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.

Board Member

He Completed His Education At Technical University of Munich In Internal Medicine/Cardiology. Eckhard U. Alt Is Professor of Medicine and Biomedical Engineering At Tulane University In New Orleans and Was Professor of Medicine At University of Texas Anderson Cancer Center In Houston and At Technical University of Munich. He Received His Medical Degree As Valedictorian From Heidelberg Medical School. After Two Years In Cardiac Surgery At the Ludwig-Maximilians-University Munich M.D.'s LinkedIn

He Worked At Acelity As Lead Product Development Engineer Developing New Negative Pressure Therapy Devices Within the Prevena and Abthera Surgical Product Lines. Before Acelity David Developed Mechanical and Electromechanical Drug Delivery Systems At Dca Design International In the Uk. David Received His Degree In Mechanical Engineering Specializing In Product Design From the University of Glasgow. David Mercer Has More Than 12 Years of Product Development Experience In Medical Devices. Previously

Board Member

He Worked At Anderson Cancer Center In the Department of Molecular Pathology. Christopher Joined Ingeneron In 2015 As European Director of Medical and Scientific Affairs Before Taking On the Role of Global Director of Medical and Scientific Affairs In 2020. Christopher Received His Medical Degree From Pmu Salzburg In Austria. Christopher Alt Has 15 Years of Research Experience In Medicine and Has A Proven Track Record of Clinical Trial Management. Previously M.D.

Board Member

He Worked At Anderson Cancer Center In the Department of Molecular Pathology. Christopher Joined Ingeneron In 2015 As European Director of Medical and Scientific Affairs Before Taking On the Role of Global Director of Medical and Scientific Affairs In 2020. Christopher Received His Medical Degree From Pmu Salzburg In Austria. Christopher Alt Has 15 Years of Research Experience In Medicine and Has A Proven Track Record of Clinical Trial Management. Previously M.D.'s LinkedIn

Inc. Bobby I. Griffin Retired From A 25-Year Career With Medtronic Where He Held Various Executive-Level Positions, Including President of Medtronic’S Crm Business From 1991 To 1998. He Manages His Own Fund of Companies and Serves On the Advisory Boards of Affinity Capital Management Fund III and IV and Sapient Capital Management Fund, In Which He Also Invests. In Addition, Bobby Has Served On the Board of Directors of Several Public Companies, Including Mts Systems Corporation and Urologix, Inc., and Is Currently A Director of Several Private Companies.

Board Member

Klaus L. Keller

Board Member

Scientific Services Inc. Jerry C. Griffin Is President of Griffin & Schwartz A Management Consulting Firm In the Health Care Products Field. He Has Assisted Several Development Stage Companies In Areas Ranging From Venture and Public Financing To Fda and Clinical Trial Strategy. He Is Currently A Member of the Boards of Directors of A Number of Private Companies. During His Academic Tenure, Jerry Held Leadership Positions In Several National and International Cardiology Organizations and Is the Author Or Coauthor of Five Books, Four Patents, and Over 170 Medical and Scientific Articles.

Board Member

Scientific Services Inc. Jerry C. Griffin Is President of Griffin & Schwartz A Management Consulting Firm In the Health Care Products Field. He Has Assisted Several Development Stage Companies In Areas Ranging From Venture and Public Financing To Fda and Clinical Trial Strategy. He Is Currently A Member of the Boards of Directors of A Number of Private Companies. During His Academic Tenure, Jerry Held Leadership Positions In Several National and International Cardiology Organizations and Is the Author Or Coauthor of Five Books, Four Patents, and Over 170 Medical and Scientific Articles.'s LinkedIn

Amber Langner

Board Member

Kent Lehr

Board Member

Annette M. Zinn

Board Member

Iowa A Native of Des Moines Lehr Holds A Bachelor’S Degree In Biochemistry and Molecular Biology From Cornell College and A Master of Business Administration and Master of Health Administration From the University of Iowa. (Iowa)

Board Member

InGeneron executives FAQs

Related company executives

Working at related companies

Related company jobs

InGeneron highest paying jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of InGeneron, including salaries, political affiliations, employee data, and more, in order to inform job seekers about InGeneron. The employee data is based on information from people who have self-reported their past or current employments at InGeneron. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by InGeneron. The data presented on this page does not represent the view of InGeneron and its employees or that of Zippia.

InGeneron may also be known as or be related to InGeneron, InGeneron Inc, InGeneron, Inc. and Ingeneron, Inc.